Researchers from Imperial College London are teaming up with Bayer Pharmaceuticals to see if artificial intelligence (AI) could accelerate the discovery of new, effective drugs for cardiovascular disease and other heart-related conditions, according to a recent news release.

A team of international researchers found using coronary CT angiography (CCTA) to determine which patients with suspected coronary artery disease (CAD) would benefit from invasive angiography can reduce costly invasive procedures while achieving similar accuracy to other methods.

Carotid pulse wave velocity (PVW) measured with ultrafast ultrasound at the end of systole (PWV-ES) may be a better biomarker of carotid stiffness in diabetic patients than PWV measured at the beginning of systole, according to a new study.

Using coronary CT angiography to identify which patients with suspected coronary artery disease (CAD) really need invasive angiography can lower the overall cost of diagnostic testing without sacrificing safety, suggests a randomized trial published Dec. 12 in JACC: Cardiovascular Imaging.

With the development of a new three-dimensional (3D) printing workflow, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston may help cardiologists produce more proficient implantable heart valves and determine how different sized valves interact for each patient before surgical intervention for aortic valve replacement, according to a Dec. 10 report by the 3D Printing Media Network.

Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review. The company offers a cloud-based artificial intelligence (AI) platform that enables the detection of 14 cardiac arrhythmias through ambulatory electrocardiogram (ECG) readings.

The FDA has granted a breakthrough device designation for an artificial intelligence (AI) pattern recognition software being developed by Bayer and Merck & Co. in New Jersey that can identify signs of chronic thromboembolic pulmonary hypertension (CTEPH)—a rare form of hypertension—in CT pulmonary angiography (CTPA) scans, according to a Dec. 3 press release.

Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.